Trust & Proof: Kanuma (Alexion Pharmaceuticals) – Signal Evidence & AI Readability

Kanuma (Alexion Pharmaceuticals)

(https://kanuma.com) 📸 Data Snapshot: May 27, 2026
Trust & Proof — The Lens

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Trust & Proof Verifiable evidence vs. Trust Theatre.
15 Impact Weight: 20 / 100
75% Reputation

The site avoids common trust theatre patterns like unverified customer reviews; the review_count is 0. However, the primary clinical reference is dated January 11, 2022, which is over 52 months old relative to the May 2026 anchor, making the evidence technically stale. While the proof_links_count is 0 in the metadata, the text provides clear paths to the full Prescribing Information and references the US National Library of Medicine DailyMed database.

The proof density is high, with a significant ratio of technical specifications to vague assertions. Specific adverse reaction data (e.g., 21 of 106 patients experiencing hypersensitivity) provides forensic-level proof of the drug’s clinical profile. The only missing element is a more current set of real-world evidence or post-market surveillance data beyond the 2022 baseline.

Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.

🛡️ Trust Signals — reviews, proof links, trust-theatre check
0Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
/hcp/ 0 0
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage — no schema detected (entity gap)
/hcp/ — no schema detected (entity gap)
Explore the other reputation pillars for Kanuma (Alexion Pharmaceuticals)